Login / Signup

Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.

Yoshitaka InoueShinya EndoNaofumi MatsunoYoshitaka KikukawaTakafumi ShichijoKenichi KogaAyumi TakakiKouta IwanagaNao NishimuraShigeo FujiTakahiro FukudaKisato NosakaMasao Matsuoka
Published in: Bone marrow transplantation (2018)
Keyphrases
  • stem cell transplantation
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • bone marrow
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • hematopoietic stem cell
  • high dose